Maroun M. Sfeir
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 15
-
- Antibiotic Use and Resistance 5
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 3
- Endocrinology top 5%
- Vibrio bacteria research studies 3
-
- Bacterial Identification and Susceptibility Testing 5
-
- Antibiotics Pharmacokinetics and Efficacy 5
-
- CRISPR and Genetic Engineering 4
- Advanced biosensing and bioanalysis techniques 4
- Co-authors
- Changchun LiuZiyue LiKun YinXiong DingEnrique BallesterosRajesh V. LallaMichael J. SatlinGülce Askin
- Partner nations
- United StatesLebanonFrance
In The Last Decade
Maroun M. Sfeir
34 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Medicine 211
- Applied Microbiology and Biotechnology 83
- Infectious Diseases 466
- Business and International Management 37
- Endocrinology 86
Countries citing papers authored by Maroun M. Sfeir
This map shows the geographic impact of Maroun M. Sfeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maroun M. Sfeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maroun M. Sfeir more than expected).
Fields of papers citing papers by Maroun M. Sfeir
This network shows the impact of papers produced by Maroun M. Sfeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maroun M. Sfeir. The network helps show where Maroun M. Sfeir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maroun M. Sfeir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 29 | |
| 9 | 2021 | 72 | |
| 10 | 2021 | 108 | |
| 11 | Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assaybreakdown → | 2020 | 672 |
| 12 | 2020 | 4 | |
| 13 | 2019 | 29 | |
| 14 | 2018 | 19 | |
| 15 | 2018 | 69 | |
| 16 | 2018 | 43 | |
| 17 | 2016 | 32 | |
| 18 | 2014 | 4 | |
| 19 | 2013 | 28 | |
| 20 | 2013 | 9 |
About Maroun M. Sfeir
Maroun M. Sfeir is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), CRISPR and Genetic Engineering (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Vibrio bacteria research studies (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Molecular Medicine (211 citations), Applied Microbiology and Biotechnology (83 citations) and Infectious Diseases (466 citations). Maroun M. Sfeir has collaborated with scholars based in United States, Lebanon and France. Frequent co-authors include Changchun Liu, Ziyue Li, Kun Yin, Xiong Ding, Enrique Ballesteros, Rajesh V. Lalla, Michael J. Satlin, Gülce Askin, Paul J. Christos and Stephen G. Jenkins. Their work appears in journals such as New England Journal of Medicine, JAMA and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.